GSK becomes partner in new global fund to accelerate dementia research
GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new global fund for dementia...
Alizé Pharma launches Phase II clinical trial of AZP-531 in Prader-Willi syndrome
Alizé Pharma, a company specialized in the development of drugs for the treatment of metabolic disorders and rare diseases, today announces the launch of...
Novartis receives FDA approval of Farydak®, the first HDAC inhibitor for patients with multiple myeloma
Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat, previously known as LBH589) capsules in combination with bortezomib*...
New nanogel for drug delivery
Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over...
Sanofi and Lead Pharma to develop treatments for autoimmune diseases
Sanofi announced today that it has entered into a research collaboration and license agreement with Dutch biotech Lead Pharma to discover, develop and commercialize...
Takeda and Orexigen receive FDA approval for new weight-loss pill called Contrave
Takeda Pharmaceuticals USA and Orexigen Therapeutics have received approval from the US Food and Drug Administration (FDA) for a new weight-loss pill...
Takeda and Orexigen Announce FDA Approval of Contrave ® (naltrexone HCI and bupropion HCI) Extended – release Tablets for Chronic Weight Management
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration (FDA) has approved Contrave® (naltrexone HCI...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...